Comparison of Post-Procedural and 30-day Post-Implantation Transcatheter Aortic Valve Replacement Gradients with and without preimplantation Balloon Valvuloplasty: A Real- World Analysis of Early Results using a Novel Balloon Expandable Transcatheter Aortic Valve

IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI:10.15212/cvia.2022.0009
M. Chandrasekhar
{"title":"Comparison of Post-Procedural and 30-day Post-Implantation Transcatheter Aortic Valve Replacement Gradients with and without preimplantation Balloon Valvuloplasty: A Real- World Analysis of Early Results using a Novel Balloon Expandable Transcatheter Aortic Valve","authors":"M. Chandrasekhar","doi":"10.15212/cvia.2022.0009","DOIUrl":null,"url":null,"abstract":"Objectives: This study describes a real-world experience of implanting a novel balloon expandable transcatheteraortic valve replacement (TAVR) compared to devices commonly used in clinical practice. As a secondary objective,the effect of balloon angioplasty (BAV) before TAVR on the transvalvular gradient 1 and 30 days after implantationwas evaluated.Background: For most commercial TAVR valves, the 30-day average mean aortic valve gradients have been reported.Our experience with the Lotus Valve System had indicated higher immediate post-implant gradients than those in the literature. We sought to evaluate both these valves, comparing them to other valves.Methods: We analyzed discharge and 30-day echocardiograms of Lotus valves from 7/5/2019 to 8/27/2020. In responseto higher-than-expected post-implant gradients, patients from 11/4/19 to 8/27/20 underwent BAV before the valve implantation, whereas patients from 7/5/19 to 10/18/19 did not (no-BAV). We compared these samples to each other and to a random sampling of TAVR valves implanted by the same interventionalist.Results: At discharge, 27 patients received Lotus valves. The average mean aortic valve gradient was 16.7 mmHg(SD = 5.5 mmHg) for the no-BAV and 14.7 mmHg (SD = 3.7 mmHg) for the BAV (P = 0.177) cohorts. No-BAV Lotus valve mean gradients were significantly higher (P < 0.001) than those of the Sapien valve (M = 12 mmHg, SD = 4.3)and CoreValve (M = 9.18 mmHg, SD = 3.96). At the 30-day assessment, the mean gradients in the no-BAV and BAV groups were similar to those in the literature (M = 11 mmHg SD 3.5; M = 12 mmHg, SD 4.1 (P = 0.287)) and those ofother valves.Conclusions: The Lotus valve demonstrated higher post-implantation gradients than other valves. This effect wasnot attenuated by BAV. These elevated gradients were not significant at the 30-day follow-up.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Innovations and Applications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15212/cvia.2022.0009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study describes a real-world experience of implanting a novel balloon expandable transcatheteraortic valve replacement (TAVR) compared to devices commonly used in clinical practice. As a secondary objective,the effect of balloon angioplasty (BAV) before TAVR on the transvalvular gradient 1 and 30 days after implantationwas evaluated.Background: For most commercial TAVR valves, the 30-day average mean aortic valve gradients have been reported.Our experience with the Lotus Valve System had indicated higher immediate post-implant gradients than those in the literature. We sought to evaluate both these valves, comparing them to other valves.Methods: We analyzed discharge and 30-day echocardiograms of Lotus valves from 7/5/2019 to 8/27/2020. In responseto higher-than-expected post-implant gradients, patients from 11/4/19 to 8/27/20 underwent BAV before the valve implantation, whereas patients from 7/5/19 to 10/18/19 did not (no-BAV). We compared these samples to each other and to a random sampling of TAVR valves implanted by the same interventionalist.Results: At discharge, 27 patients received Lotus valves. The average mean aortic valve gradient was 16.7 mmHg(SD = 5.5 mmHg) for the no-BAV and 14.7 mmHg (SD = 3.7 mmHg) for the BAV (P = 0.177) cohorts. No-BAV Lotus valve mean gradients were significantly higher (P < 0.001) than those of the Sapien valve (M = 12 mmHg, SD = 4.3)and CoreValve (M = 9.18 mmHg, SD = 3.96). At the 30-day assessment, the mean gradients in the no-BAV and BAV groups were similar to those in the literature (M = 11 mmHg SD 3.5; M = 12 mmHg, SD 4.1 (P = 0.287)) and those ofother valves.Conclusions: The Lotus valve demonstrated higher post-implantation gradients than other valves. This effect wasnot attenuated by BAV. These elevated gradients were not significant at the 30-day follow-up.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经导管主动脉瓣置换术后和植入术后30天经导管主动脉瓣置换术梯度与不经球囊瓣膜成形术的比较:一种新型球囊可扩张经导管主动脉瓣早期结果的真实世界分析
目的:本研究描述了一种新型球囊可扩张经导管主动脉瓣置换术(TAVR)的实际植入经验,与临床实践中常用的设备进行了比较。作为次要目标,评估TAVR前球囊血管成形术(BAV)对植入后1天和30天经瓣梯度的影响。背景:对于大多数商业化的TAVR瓣膜,30天平均主动脉瓣梯度已被报道。我们使用Lotus瓣膜系统的经验表明,植入后即刻的梯度比文献中更高。我们试图评估这两个瓣膜,并将它们与其他瓣膜进行比较。方法:分析2019年7月5日至2020年8月27日莲花瓣膜的出院和30天超声心动图。为了应对高于预期的植入后梯度,11/4/19至8/27/20的患者在瓣膜植入前接受了BAV,而7/5/19至10/18/19的患者没有(无BAV)。我们将这些样本相互比较,并与同一位介入医生随机植入的TAVR瓣膜样本进行比较。结果:出院时,27例患者接受莲花瓣膜置换术。无BAV组平均主动脉瓣梯度为16.7 mmHg(SD = 5.5 mmHg), BAV组平均主动脉瓣梯度为14.7 mmHg(SD = 3.7 mmHg) (P = 0.177)。No-BAV Lotus瓣膜的平均梯度显著高于Sapien瓣膜(M = 12 mmHg, SD = 4.3)和CoreValve瓣膜(M = 9.18 mmHg, SD = 3.96) (P < 0.001)。在30天的评估中,无BAV组和BAV组的平均梯度与文献中相似(M = 11 mmHg SD 3.5;M = 12 mmHg, SD 4.1 (P = 0.287))和其他瓣膜。结论:荷叶瓣膜植入后梯度高于其他瓣膜。BAV没有减弱这种效应。在30天的随访中,这些升高的梯度并不显著。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardiovascular Innovations and Applications
Cardiovascular Innovations and Applications CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
0.80
自引率
20.00%
发文量
222
期刊最新文献
Mechanisms of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure Incidence, Predictors and Associations Between In-Hospital Bleeding and Adverse Events in Patients with Acute Coronary Syndrome Above 75 Years of Age – The Real-World Scenario Single-Cell RNA Sequencing Maps Immune Cell Heterogeneity in Mice with Allogeneic Cardiac Transplantation Coronavirus Disease 2019, Myocardial Injury, and Myocarditis Predictive Value of a Combination of the Age, Creatinine and Ejection Fraction (ACEF) Score and Fibrinogen Level in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1